These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 36835633)

  • 1. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Search of a Function for the N6-Methyladenosine in Epitranscriptome, Autophagy and Neurodegenerative Diseases.
    Suga N; Ikeda Y; Yoshikawa S; Taniguchi K; Sawamura H; Matsuda S
    Neurol Int; 2023 Aug; 15(3):967-979. PubMed ID: 37606395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
    Jayasree PJ; Dutta S; Karemore P; Khandelia P
    Mol Biotechnol; 2024 Nov; 66(11):3042-3058. PubMed ID: 37831403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer.
    Mao-Mao ; Zhang JJ; Xu YP; Shao MM; Wang MC
    Drug Discov Today; 2024 Feb; 29(2):103875. PubMed ID: 38176674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into N6-methyladenosine and programmed cell death in cancer.
    Liu L; Li H; Hu D; Wang Y; Shao W; Zhong J; Yang S; Liu J; Zhang J
    Mol Cancer; 2022 Jan; 21(1):32. PubMed ID: 35090469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
    Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
    Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress of N6-methyladenosine in colorectal cancer: A review.
    Lin Y; Shi H; Wu L; Ge L; Ma Z
    Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.
    Dou Z; Ma XT; Piao MN; Wang JP; Li JL
    Transl Cancer Res; 2024 Jun; 13(6):3106-3125. PubMed ID: 38988908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modification of m
    Wang Y; Wang Y; Patel H; Chen J; Wang J; Chen ZS; Wang H
    Mol Cancer; 2023 Jun; 22(1):102. PubMed ID: 37391814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M6A RNA methylation in biliary tract cancer: the function roles and potential therapeutic implications.
    Bai X; Huang J; Jin Y; Chen J; Zhou S; Dong L; Han X; He X
    Cell Death Discov; 2024 Feb; 10(1):83. PubMed ID: 38365891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of m6A-Mediated DNA Damage Repair in Tumor Development and Chemoradiotherapy Resistance.
    Qu L; Liu SJ; Zhang L; Liu JF; Zhou YJ; Zeng PH; Jing QC; Yin WJ
    Cancer Control; 2024; 31():10732748241247170. PubMed ID: 38662732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases.
    Chen X; Wang J; Tahir M; Zhang F; Ran Y; Liu Z; Wang J
    Cell Biosci; 2021 Jul; 11(1):147. PubMed ID: 34315538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
    Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
    Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma.
    Du J; Hou K; Mi S; Ji H; Ma S; Ba Y; Hu S; Xie R; Chen L
    Front Oncol; 2020; 10():208. PubMed ID: 32211315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.